Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alexey O. Bueverov"'
Autor:
Alessio Aghemo, Olga P. Alekseeva, Francesco Angelico, Igor G. Bakulin, Natalia V. Bakulina, Dmitry Bordin, Alexey O. Bueverov, Oxana M. Drapkina, Anton Gillessen, Elvira M. Kagarmanova, Natalia V. Korochanskaya, U. A. Kucheryavii, Leonid B. Lazebnik, Maria A. Livzan, Igor V. Maev, Anatolii I. Martynov, Marina F. Osipenko, Evgenii I. Sas, Antonina Starodubova, Yurii P. Uspensky, Elena V. Vinnitskaya, Emilia P. Yakovenko, Alexey A. Yakovlev
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1548-1560 (2022)
Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately—hepatocellular carcinoma (HCC) if left untreated. The different phenotypes of CLD
Externí odkaz:
https://doaj.org/article/7d10951835b3480689eeb4537fc49f90
Autor:
Pavel O. Bogomolov, Vladimir T. Ivashkin, Alexey O. Bueverov, Igor V. Maev, Olga I. Sagalova, Snezhana S. Sleptsova, Nikolay D. Yushuk, Denis A. Gusev, Konstantin V. Zhdanov, Vladimir P. Chulanov
Publikováno v:
Терапевтический архив, Vol 93, Iss 11, Pp 1290-1299 (2021)
Aim. To study the efficacy and safety of bulevirtide, the HBV and HDV entry inhibitor. Materials and methods. Analysis of the results of using bulevirtide in randomized controlled open-label comparative studies MYR202 and MYR203 in 56 patients wit
Externí odkaz:
https://doaj.org/article/dd4f639c7df44744a2a36d995ab5afcd
Autor:
Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Ekaterina O. Liusina, Alexey O. Bueverov
Publikováno v:
Сахарный диабет, Vol 23, Iss 5, Pp 412-423 (2021)
BACKGROUND: The number of patients with chronic metabolic disorders such as obesity, type 2 diabetes mellitus (T2D) and non-alcoholic fatty liver disease (NAFLD) is growing at an alarming rate worldwide in both developed and developing countries. In
Externí odkaz:
https://doaj.org/article/9262e35facd54cbf93dc2426c8c04790
Publikováno v:
Annals of the Russian academy of medical sciences. 76:595-603
Background. Drug treatment of non-alcoholic fatty and alcoholic liver disease remains an urgent, unsolved problem. Due to the commonality of many pathogenetic mechanisms and predictors of progression, a universal approach to the search for a therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ffbc99fd20496af4cdd396e16cbae97
https://doi.org/10.15690/vramn1576
https://doi.org/10.15690/vramn1576
Autor:
Pavel O. Bogomolov, Ekaterina E. Mishina, Ekaterina O. Liusina, Alexander Yur'evich Mayorov, Alexey O. Bueverov
Publikováno v:
Сахарный диабет, Vol 23, Iss 5, Pp 412-423 (2021)
BACKGROUND: The number of patients with chronic metabolic disorders such as obesity, type 2 diabetes mellitus (T2D) and non-alcoholic fatty liver disease (NAFLD) is growing at an alarming rate worldwide in both developed and developing countries. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8de7d5f9365b2fd5ccfae8e5baec50
https://www.dia-endojournals.ru/jour/article/view/12234
https://www.dia-endojournals.ru/jour/article/view/12234
Autor:
Alexey O. Bueverov, Pavel O. Bogomolov
Publikováno v:
Высокотехнологическая медицина. 8:24-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b42728ee451aedcafef5dc61904d8c74
https://doi.org/10.52090/2542-1646_2021_8_2_24
https://doi.org/10.52090/2542-1646_2021_8_2_24
Autor:
Pavel O. Bogomolov, Vladimir T. Ivashkin, Alexey O. Bueverov, Igor V. Maev, Olga I. Sagalova, Snezhana S. Sleptsova, Nikolay D. Yushuk, Denis A. Gusev, Konstantin V. Zhdanov, Vladimir P. Chulanov
Publikováno v:
Терапевтический архив, Vol 93, Iss 11, Pp 1290-1299 (2021)
To study the efficacy and safety of bulevirtide, the HBV and HDV entry inhibitor.Analysis of the results of using bulevirtide in randomized controlled open-label comparative studies MYR202 and MYR203 in 56 patients with chronic hepatitis D and compen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a12ea68afa380ca48d907e4a1413551
https://pubmed.ncbi.nlm.nih.gov/36286651
https://pubmed.ncbi.nlm.nih.gov/36286651
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 197-203 (2017)
To identify predictors for the high efficiency of short-term interferon-containing antiviral therapy (AVT) using direct-acting antivirals (DAAs) in patients with chronic hepatitis C (CHC) virus (HCV) type 1 (CHC-1).A total of 2,798 case histories of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29acef63d923b89914970e29be83cfbf
https://doi.org/10.17116/terarkh20178912197-203
https://doi.org/10.17116/terarkh20178912197-203
Autor:
O. S. Kuz'mina, Natalia Voronkova, K. Yu. Kokina, Alexey O. Bueverov, Pavel O. Bogomolov, M. V. Matsievich
Publikováno v:
Almanac of Clinical Medicine. :126-131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86d8c924d928178b8b8d69cfae2ea2d0
https://doi.org/10.18786/2072-0505-2015-40-126-131
https://doi.org/10.18786/2072-0505-2015-40-126-131
Autor:
T. N. Sheshukova, O. V. Uvarova, S. V. Ivannikova, L. S. Gorbunova, M. N. Trofimova, I. N. Azarova, K. Yu. Kokina, Alexey O. Bueverov, E. M. Kondratenko, E. N. Cherenkova, O. A. Kudrya, S. V. Koblov, I. M. Shilkina, I. N. Kovalev, M. Yu. Petrachenkova, Pavel O. Bogomolov, M. V. Matsievich, S. I. Kiyan, Natalia Voronkova, G. G. Chernyavskaya, Yu. Yu. Gumerova, O. S. Kuz'mina, V. D. Beznosenko, E. V. Fedosova, E. N. Kudryavtseva, G. V. Sadovskaya, N. A. Gorshilina, N. V. Kosheleva, V. A. Sinitsyna, M. L. Samsonyan
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 40, Pp 48-57 (2016)
Background: The beginning of a new era of direct acting antivirals sets up its own rules, that is, to achieve the highest efficacy with the shortest duration of treatment. It is assumed that the use of the first generation of direct acting antivirals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b9176f2d85fd821fb6fc61aa609a08
https://doi.org/10.18786/2072-0505-2015-40-48-57
https://doi.org/10.18786/2072-0505-2015-40-48-57